Close Menu
ceofeature.com

    Subscribe to Updates

    Subscribe to our newsletter for the latest leadership tips, exclusive interviews, and expert advice from top CEOs. Simply enter your email below and stay ahead of the curve!.

    What's Hot

    Euro strength reflects dollar weakness, possibly politically driven, says ECB’s Kocher

    February 6, 2026

    Dollar set for strong weekly gain; euro, sterling bounce

    February 6, 2026

    GBP/CHF set to rise as safe-haven demand for Swiss franc wanes, UBS says

    February 6, 2026
    Facebook X (Twitter) Instagram
    ceofeature.com
    ceofeature.com
    ceofeature.com
    • Home
    • Business
    • Lifestyle
    • CEO News
    • Investing
    • Opinion
    • Market
    • Magazine
    Facebook X (Twitter) Instagram YouTube
    Subscribe
    ceofeature.com
    Home Space startup Varda raises $187 million to make drugs in orbit
    Business

    Space startup Varda raises $187 million to make drugs in orbit

    Daniel snowBy Daniel snowJuly 10, 20252 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email Copy Link


    Pavlo Gonchar | Lightrocket | Getty Images

    Space startup Varda announced on Thursday that it has raised $187 million in Series C funding, led by venture capital firms Natural Capital and Shrug Capital, to continue advancing drug manufacturing in space.

    The latest round included participation from Peter Thiel, Lux Capital, Khosla Ventures and Caffeinated Capital. It brought the total capital Varda’s raised to $329 million.

    “By expanding, we can support work on more complex molecules and ultimately increase cadence to achieve the turnaround times the pharmaceutical industry expects,” Chief Science Officer Adrian Radocea said in a press release Thursday.

    Varda’s main mission is to launch and return drugs made in space. The startup has said the medicines crystallize differently in orbit due to the gravity differences, which would allow it to complete drugs that are currently difficult to manufacture.

    In 2024, the space startup’s W-Series 1 capsule received FAA approval to return after successfully creating the drug Ritonavir the previous year.

    So far, Varda said the company has been able to complete three space launches. Now, a fourth is in orbit, and the company expects to launch a fifth by the end of the year. Varda’s system uses Rocket Lab’s Photon spacecraft for its operation and adds its manufacturing module and a heatshield-protected capsule.

    “With this capital, Varda will continue to increase our flight cadence and build out the pharmaceutical lab that will deliver the world’s first microgravity-enabled drug formulation,” said Varda CEO Will Bruey.

    Varda Space Industries is the first company to process materials outside the International Space Station.

    Recently, the space company has also operated a testbed for the U.S. government to use the W-series reentry vehicles to advance technology.

    Varda said it has expanded into Huntsville, Alaska, and opened a laboratory in El Segundo, California, to begin work to crystallize more drugs.

    “Our new lab space is an investment in our belief that in-space pharmaceutical manufacturing will drive the foundation of the orbital economy,” Radocea said.



    Source link

    Follow on Google News Follow on Flipboard
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Daniel snow
    • Website

    Related Posts

    Matthew Steven Attalla, aka Mateo: True Disruptor of the Fitness World

    February 2, 2026

    Why Barry Callebaut’s CEO Exit Signals a Strategic Turning Point

    February 2, 2026

    Acun Ilıcalı and Esat Yontunç Named in Expanding Investigation as Authorities Remain Silent

    January 27, 2026
    Leave A Reply Cancel Reply

    Top Posts

    What Happens When a Teen Prodigy Becomes a Power CEO?

    September 15, 2025

    Acun Ilıcalı and Esat Yontunç Named in Expanding Investigation as Authorities Remain Silent

    January 27, 2026

    Queen of the North: How Ravinna Raveenthiran is Redefining Real Estate with Resilience and Compassion

    October 22, 2024

    Redefining leadership and unlocking human potential, Meet Janice Elsley

    June 4, 2025
    Don't Miss

    Euro strength reflects dollar weakness, possibly politically driven, says ECB’s Kocher

    By Daniel snowFebruary 6, 2026

    Euro strength reflects dollar weakness, possibly politically driven, says ECB’s Kocher Source link

    Dollar set for strong weekly gain; euro, sterling bounce

    February 6, 2026

    GBP/CHF set to rise as safe-haven demand for Swiss franc wanes, UBS says

    February 6, 2026

    EUR/GBP to remain range-bound as budget risk premium fades: UBS

    February 6, 2026
    Stay In Touch
    • Facebook
    • Twitter

    Subscribe to Updates

    Subscribe to our newsletter for the latest leadership tips, exclusive interviews, and expert advice from top CEOs. Simply enter your email below and stay ahead of the curve!.

    About Us
    About Us

    Welcome to CEO Feature, where we dive deep into the exhilarating world of entrepreneurs and CEOs from across the globe! Brace yourself for captivating stories that will blow your mind and leave you inspired.

    Facebook X (Twitter)
    Featured Posts

    The Art of Private Luxury – Vanke Jinyu Huafu by Mr. Tony Tandijono

    September 28, 2018

    5 Simple Tips to Take Care of Larger Air Balloons

    January 4, 2020

    5 Ways Your Passport Can Ruin Your Cool Holiday Trip

    January 5, 2020
    Worldwide News

    5 Flavoursome Pizza Shops you Should Check Out in Toronto

    January 13, 20210

    Save $90 on The HS700E 4K Drone, An Ideal Beginner

    January 14, 20210

    Cryptographers Are Not Happy With How Using the Word ‘Crypto’

    January 14, 20210
    • www.ceofeature.com
    @2025 copyright by ceofeature

    Type above and press Enter to search. Press Esc to cancel.